Dr. Frederic Moll is the CEO of PROCEPT BioRobotics Corporation and has had quite an impressive journey in the field of medicine and medical technology. With a medical degree from Stanford University and a background in biology from UC Berkeley,...
Dr. Frederic Moll is the CEO of PROCEPT BioRobotics Corporation and has had quite an impressive journey in the field of medicine and medical technology. With a medical degree from Stanford University and a background in biology from UC Berkeley, he has dedicated his career to advancing healthcare solutions. Before leading PROCEPT, he co-founded Auris Health, where he served as CEO, helping innovate robotic surgical systems before Johnson & Johnson acquired the company. Dr. Moll also held significant roles in various healthcare companies, showcasing his deep expertise. What’s interesting is that in 2023, his total compensation reached an impressive $25.7 million, driven by a large stock vesting and bonus payouts tied to company performance. Under his leadership, PROCEPT is focused on creating advanced robotics solutions for treating prostate conditions. His ability to lead and innovate in a cutting-edge field distinguishes him in the tech and healthcare industries.